Natalia V Solenkova1, Jonathan D Newman2, Jeffrey S Berger2, George Thurston3, Judith S Hochman2, Gervasio A Lamas4. 1. Department of Medicine, Mount Sinai Medical Center, Miami Beach, FL. 2. Leon H Charney Division of Cardiology, New York University School of Medicine, New York, NY. 3. Nelson Institute of Environmental Medicine, New York University School of Medicine, New York, NY. 4. Department of Medicine, Mount Sinai Medical Center, Miami Beach, FL; Columbia University Division of Cardiology at Mount Sinai Medical Center, Miami Beach FL.
Abstract
INTRODUCTION: There is epidemiological evidence that metal contaminants may play a role in the development of atherosclerosis and its complications. Moreover, a recent clinical trial of a metal chelator had a surprisingly positive result in reducing cardiovascular events in a secondary prevention population, strengthening the link between metal exposure and cardiovascular disease (CVD). This is, therefore, an opportune moment to review evidence that exposure to metal pollutants, such as arsenic, lead, cadmium, and mercury, is a significant risk factor for CVD. METHODS: We reviewed the English-speaking medical literature to assess and present the epidemiological evidence that 4 metals having no role in the human body (xenobiotic), mercury, lead, cadmium, and arsenic, have epidemiologic and mechanistic links to atherosclerosis and CVD. Moreover, we briefly review how the results of the Trial to Assess Chelation Therapy (TACT) strengthen the link between atherosclerosis and xenobiotic metal contamination in humans. CONCLUSIONS: There is strong evidence that xenobiotic metal contamination is linked to atherosclerotic disease and is a modifiable risk factor.
INTRODUCTION: There is epidemiological evidence that metal contaminants may play a role in the development of atherosclerosis and its complications. Moreover, a recent clinical trial of a metal chelator had a surprisingly positive result in reducing cardiovascular events in a secondary prevention population, strengthening the link between metal exposure and cardiovascular disease (CVD). This is, therefore, an opportune moment to review evidence that exposure to metal pollutants, such as arsenic, lead, cadmium, and mercury, is a significant risk factor for CVD. METHODS: We reviewed the English-speaking medical literature to assess and present the epidemiological evidence that 4 metals having no role in the human body (xenobiotic), mercury, lead, cadmium, and arsenic, have epidemiologic and mechanistic links to atherosclerosis and CVD. Moreover, we briefly review how the results of the Trial to Assess Chelation Therapy (TACT) strengthen the link between atherosclerosis and xenobiotic metal contamination in humans. CONCLUSIONS: There is strong evidence that xenobiotic metal contamination is linked to atherosclerotic disease and is a modifiable risk factor.
Authors: Denis Nash; Laurence Magder; Mark Lustberg; Roger W Sherwin; Robert J Rubin; Rachel B Kaufmann; Ellen K Silbergeld Journal: JAMA Date: 2003-03-26 Impact factor: 56.272
Authors: Maria Tellez-Plaza; Ana Navas-Acien; Ciprian M Crainiceanu; A Richey Sharrett; Eliseo Guallar Journal: Am J Epidemiol Date: 2010-08-06 Impact factor: 4.897
Authors: Gervasio A Lamas; Christine Goertz; Robin Boineau; Daniel B Mark; Theodore Rozema; Richard L Nahin; Lauren Lindblad; Eldrin F Lewis; Jeanne Drisko; Kerry L Lee Journal: JAMA Date: 2013-03-27 Impact factor: 56.272
Authors: Michael J Kosnett; Richard P Wedeen; Stephen J Rothenberg; Karen L Hipkins; Barbara L Materna; Brian S Schwartz; Howard Hu; Alan Woolf Journal: Environ Health Perspect Date: 2006-12-22 Impact factor: 9.031
Authors: Maria Tellez-Plaza; Matthew O Gribble; V Saroja Voruganti; Kevin A Francesconi; Walter Goessler; Jason G Umans; Ellen K Silbergeld; Eliseo Guallar; Nora Franceschini; Kari E North; Wen H Kao; Jean W MacCluer; Shelley A Cole; Ana Navas-Acien Journal: Environ Health Perspect Date: 2013-01-15 Impact factor: 9.031
Authors: Cheng Chen; Pengcheng Xun; Leslie A McClure; John Brockman; Leslie MacDonald; Mary Cushman; Jianwen Cai; Lisa Kamendulis; Jason Mackey; Ka He Journal: Environ Int Date: 2018-05-05 Impact factor: 9.621
Authors: Thomas E Fuller-Rowell; David S Curtis; Pamela K Klebanov; Jeanne Brooks-Gunn; Gary W Evans Journal: Am J Epidemiol Date: 2017-05-15 Impact factor: 4.897
Authors: Maureen R Gwinn; Daniel A Axelrad; Tina Bahadori; David Bussard; Wayne E Cascio; Kacee Deener; David Dix; Russell S Thomas; Robert J Kavlock; Thomas A Burke Journal: Am J Public Health Date: 2017-05-18 Impact factor: 9.308
Authors: Arce Domingo-Relloso; Maria Grau-Perez; Laisa Briongos-Figuero; Jose L Gomez-Ariza; Tamara Garcia-Barrera; Antonio Dueñas-Laita; Jennifer F Bobb; F Javier Chaves; Marianthi-Anna Kioumourtzoglou; Ana Navas-Acien; Josep Redon-Mas; Juan C Martin-Escudero; Maria Tellez-Plaza Journal: Int J Epidemiol Date: 2019-12-01 Impact factor: 7.196